TORONTO and GLIL YAM, Israel, Dec. 12, 2025 — IM Cannabis Corp. (“IMC” or the “Company”) (Nasdaq: IMCC), a leading medical cannabis company with operations in Israel and Germany, today announced—building on its October 29, 2025 press release—the immediate appointment of Asi Levi, CPA, as the Company’s Chief Financial Officer (“CFO”), succeeding Uri Birenberg.

Mr. Levi brings more than 15 years of finance and control experience, having held CFO roles at Water Ways Technologies Inc. and DekelOil CI (a unit of Dekel Agri-Vision Plc), as well as controller positions at SciSparc Ltd. and A2Z Cust2Mate Solutions Corp. His expertise includes leading fundraising initiatives and managing financial planning, budgeting, and cash flow while adhering to International Financial Reporting Standards (IFRS) and other regulatory requirements.

The Company expresses gratitude to Mr. Birenberg for his work during his time as CFO and extends best wishes for his future pursuits.

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) is a global cannabis firm supplying premium products to medical patients in Israel and Germany—two of the world’s top medical cannabis markets. The Company has directed its resources toward achieving sustainable, profitable growth in its key markets: Israel and Germany. It utilizes a cross-border ecosystem fueled by a distinctive data-driven strategy and a globally sourced product supply chain. Committed to responsible expansion and compliance with stringent regulations, the Company aims to enhance its commercial and brand influence to become a leading global provider of high-quality cannabis.

In Israel, the IMC ecosystem functions via its subsidiaries, which import and distribute cannabis to medical patients using years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistics hubs in Israel—ensuring safe delivery and quality control of IMC products across the entire value chain. In Germany, IMC operates through Adjupharm GmbH, distributing cannabis to pharmacies for medical patients.

Company Contact:

Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338

Oren Shuster, Chief Executive Officer
IM Cannabis Corp.

Logo –

SOURCE IM Cannabis Corp.